Pharmacological inhibition of lipolysis prevents adverse metabolic outcomes during glucocorticoid administration-Reference-Cited by-同舟云学术

Pharmacological inhibition of lipolysis prevents adverse metabolic outcomes during glucocorticoid administration

Published:2023-08 Issue: Volume:74 Page:101751
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Linden Melissa A.,Burke Susan J.,Pirzadah Humza A.,Huang Tai-Yu,Batdorf Heidi M.,Mohammed Walid K.,Jones Katarina A.,Ghosh Sujoy,Campagna Shawn R.,Collier J. Jason,Noland Robert C.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference57 articles.

1. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study;Waljee;BMJ,2017

2. Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark;Laugesen;Eur J Endocrinol,2019

3. Prevalence of oral glucocorticoid usage in the United States: a general population perspective;Overman;Arthritis Care Res (Hoboken),2013

4. Glucocorticoids and skeletal muscle;Bodine;Adv Exp Med Biol,2015

5. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice;Hu;J Clin Investig,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes-induced muscle wasting: molecular mechanisms and promising therapeutic targets;Critical Reviews in Food Science and Nutrition;2024-07-25

2. Acute Deletion of the Glucocorticoid Receptor in Hepatocytes Disrupts Postprandial Lipid Metabolism in Male Mice;Endocrinology;2023-08-23